NEW YORK, May 2 – Transgenomic has signed an agreement to acquire Annovis, a San Diego-based nucleic acid and reagent maker, for 1.9 million shares of Transgenomic common stock and $500,000 in cash, the companies announced Wednesday.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.